Performance of a diagnostic algorithm for fibrotic hypersensitivity pneumonitis. A case–control study

by Sabina A. Guler, Eva Wohlfarth, Sabina Berezowska, Thomas K. Geiser, Lukas Ebner, Manuela Funke-Chambour
Published 2021-04-01

Serum calprotectin as new biomarker for disease severity in idiopathic pulmonary fibrosis: a cross-sectional study in two independent cohorts

by Sabina A. Guler, Michael P. Horn, Lurdes Planas-Cerezales, Ana Montes-Worboys, Thomas K. Geiser, Manuela Funke-Chambour
Published 2021-08-01

Correction to: Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls

by Kristina Krempaska, Sandra Barnowski, Jacopo Gavini, Nina Hobi, Simone Ebener, Cedric Simillion, Andrea Stokes, Ronja Schliep, Lars Knudsen, Thomas K. Geiser, Manuela Funke-Chambour
Published 2020-01-01

Azithromycin has enhanced effects on lung fibroblasts from idiopathic pulmonary fibrosis (IPF) patients compared to controls

by Kristina Krempaska, Sandra Barnowski, Jacopo Gavini, Nina Hobi, Simone Ebener, Cedric Simillion, Andrea Stokes, Ronja Schliep, Lars Knudsen, Thomas K. Geiser, Manuela Funke-Chambour
Published 2020-01-01